Literature DB >> 29194146

Risk Factors of Impaired Neuropsychologic Outcome in School-Aged Survivors of Neonatal Critical Illness.

Lisette Leeuwen1, Raisa M Schiller1, André B Rietman1, Joost van Rosmalen2, Enno D Wildschut1, Robert Jan M Houmes1, Dick Tibboel1, Hanneke IJsselstijn1.   

Abstract

OBJECTIVE: Until now, long-term outcome studies have focused on general cognitive functioning and its risk factors following neonatal extracorporeal membrane oxygenation and/or congenital diaphragmatic hernia. However, it is currently unknown which neuropsychological domains are most affected in these patients and which clinical variables can be used to predict specific neuropsychological problems. This study aimed to identify affected neuropsychological domains and its clinical determinants in survivors of neonatal extracorporeal membrane oxygenation and/or congenital diaphragmatic hernia.
DESIGN: Prospective follow-up study.
SETTING: Tertiary university hospital. PATIENTS: Sixty-five 8-year-old survivors of neonatal extracorporeal membrane oxygenation and/or congenital diaphragmatic hernia.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Intelligence, attention, memory, executive functioning and visuospatial processing were evaluated using validated tests and compared with Dutch reference data. Assessed risk factors of outcome were illness severity indicators, number of anesthetic procedures in the first year of life, and growth at 1 year. Patients had average intelligence (mean intelligence quotient ± SD, 95 ± 16), but significantly poorer sustained attention (mean z score ± SD, -2.73 ± 2.57), verbal (immediate, -1.09 ± 1.27; delayed, -1.14 ± 1.86), and visuospatial memory (immediate, -1.48 ± 1.02; delayed, -1.57 ± 1.01; recognition, -1.07 ± 3.10) than the norm. Extracorporeal membrane oxygenation-treated congenital diaphragmatic hernia patients had significantly lower mean intelligence quotient (84 ± 12) than other neonatal extracorporeal membrane oxygenation patients (94 ± 10) and congenital diaphragmatic hernia patients not treated with extracorporeal membrane oxygenation (100 ± 20). Maximum vasoactive-inotropic score was negatively associated with delayed verbal (B = -0.02; 95% CI, -0.03 to -0.002; p = 0.026) and visuospatial memory (B = -0.01; 95% CI, -0.02 to -0.001; p = 0.024).
CONCLUSIONS: We found memory and attention deficits in 8-year-old neonatal extracorporeal membrane oxygenation and congenital diaphragmatic hernia survivors. The maximum dose of vasoactive medication was negatively associated with verbal and visuospatial memory, which may suggest an effect of early cerebral hypoperfusion in determining these abnormalities.

Entities:  

Mesh:

Year:  2018        PMID: 29194146     DOI: 10.1097/CCM.0000000000002869

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  Pharmacokinetic modeling of intravenous sildenafil in newborns with congenital diaphragmatic hernia.

Authors:  Suzan C M Cochius-den Otter; Florian Kipfmueller; Brenda C M de Winter; Karel Allegaert; Dick Tibboel; Andreas Mueller; Birgit C P Koch
Journal:  Eur J Clin Pharmacol       Date:  2019-11-18       Impact factor: 2.953

Review 2.  Congenital diaphragmatic hernia.

Authors:  Augusto Zani; Wendy K Chung; Jan Deprest; Matthew T Harting; Tim Jancelewicz; Shaun M Kunisaki; Neil Patel; Lina Antounians; Pramod S Puligandla; Richard Keijzer
Journal:  Nat Rev Dis Primers       Date:  2022-06-01       Impact factor: 52.329

3.  Parent-Reported Perceived Cognitive Functioning Identifies Cognitive Problems in Children Who Survived Neonatal Critical Illness.

Authors:  Yerel Ilik; Hanneke IJsselstijn; Saskia J Gischler; Annabel van Gils-Frijters; Johannes M Schnater; Andre B Rietman
Journal:  Children (Basel)       Date:  2022-06-16

4.  Neonatal Pain, Opioid, and Anesthetic Exposure; What Remains in the Human Brain After the Wheels of Time?

Authors:  Gerbrich E van den Bosch; Dick Tibboel; Jurgen C de Graaff; Hanan El Marroun; Aad van der Lugt; Tonya White; Monique van Dijk
Journal:  Front Pediatr       Date:  2022-05-11       Impact factor: 3.569

Review 5.  Neurocognitive Outcome After Treatment With(out) ECMO for Neonatal Critical Respiratory or Cardiac Failure.

Authors:  Raisa M Schiller; Dick Tibboel
Journal:  Front Pediatr       Date:  2019-11-26       Impact factor: 3.418

6.  Feasibility of Doppler Ultrasound for Cortical Cerebral Blood Flow Velocity Monitoring During Major Non-cardiac Surgery of Newborns.

Authors:  Sophie A Costerus; Anna J Kortenbout; Hendrik J Vos; Paul Govaert; Dick Tibboel; René M H Wijnen; Nico de Jong; Johan G Bosch; Jurgen C de Graaff
Journal:  Front Pediatr       Date:  2021-03-22       Impact factor: 3.418

7.  Cerebral Oxygenation and Activity During Surgical Repair of Neonates With Congenital Diaphragmatic Hernia: A Center Comparison Analysis.

Authors:  Sophie A Costerus; Dries Hendrikx; Joen IJsselmuiden; Katrin Zahn; Alba Perez-Ortiz; Sabine Van Huffel; Robert B Flint; Alexander Caicedo; René Wijnen; Lucas Wessel; Jurgen C de Graaff; Dick Tibboel; Gunnar Naulaers
Journal:  Front Pediatr       Date:  2021-12-17       Impact factor: 3.418

Review 8.  Neurocognitive functioning and health-related quality of life of children after pediatric intensive care admission: a systematic review.

Authors:  José A Hordijk; Sascha C Verbruggen; Corinne M Buysse; Elisabeth M Utens; Koen F Joosten; Karolijn Dulfer
Journal:  Qual Life Res       Date:  2022-03-31       Impact factor: 3.440

9.  Fetal cerebrovascular impedance is reduced in left congenital diaphragmatic hernia.

Authors:  K A Kosiv; A Moon-Grady; W Hogan; R Keller; R Rapoport; E Rogers; V A Feldstein; H Lee; S Peyvandi
Journal:  Ultrasound Obstet Gynecol       Date:  2021-03       Impact factor: 7.299

Review 10.  Improving Long-Term Outcomes After Extracorporeal Membrane Oxygenation: From Observational Follow-Up Programs Toward Risk Stratification.

Authors:  Hanneke IJsselstijn; Maayke Hunfeld; Raisa M Schiller; Robert J Houmes; Aparna Hoskote; Dick Tibboel; Arno F J van Heijst
Journal:  Front Pediatr       Date:  2018-06-26       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.